Abuse-Deterrent Opioids (Reprinted from The Medical Letter on Drugs and Therapeutics vol 59, pg 95-96, 2017)

被引:3
作者
Abramowicz, Mark
Zuccotti, Gianna
Pflomm, Jean-Marie
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2018年 / 319卷 / 19期
关键词
EXTENDED-RELEASE OXYCODONE; OXYCONTIN;
D O I
10.1001/jama.2018.4996
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2036 / +
页数:2
相关论文
共 12 条
[1]  
[Anonymous], 2017, MED LETT DRUGS THER, V59, P68
[2]  
[Anonymous], 2016, MED LETT DRUGS THER, V58, P77
[3]  
[Anonymous], 2015, MED LETT DRUGS THER, V57, P119
[4]  
[Anonymous], MED LETT DR IN PRESS
[5]   OPIOIDS, SUBSTANCE ABUSE & ADDICTIONS SECTION [J].
Cassidy, Theresa A. ;
DasMahapatra, Pronabesh ;
Black, Ryan A. ;
Wieman, Matthew S. ;
Butler, Stephen F. .
PAIN MEDICINE, 2014, 15 (03) :440-451
[6]   Effect of Abuse-Deterrent Formulation of OxyContin [J].
Cicero, Theodore J. ;
Ellis, Matthew S. ;
Surratt, Hilary L. .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02) :187-189
[7]   The Effect of an Abuse-Deterrent Opioid Formulation (OxyContin) on Opioid Abuse-Related Outcomes in the Postmarketing Setting [J].
Coplan, P. M. ;
Chilcoat, H. D. ;
Butler, S. F. ;
Sellers, E. M. ;
Kadakia, A. ;
Harikrishnan, V. ;
Haddox, J. D. ;
Dart, R. C. .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2016, 100 (03) :275-286
[8]   Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics [J].
Coplan, Paul M. ;
Kale, Hrishikesh ;
Sandstrom, Lauren ;
Landau, Craig ;
Chilcoat, Howard D. .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 (12) :1274-1282
[9]   The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study [J].
Degenhardt, Louisa ;
Bruno, Raimondo ;
Ali, Robert ;
Lintzeris, Nicholas ;
Farrell, Michael ;
Larance, Briony .
DRUG AND ALCOHOL DEPENDENCE, 2015, 151 :56-67
[10]  
FDA, 2015, AB DET OP EV LAB GUI